Source:http://linkedlifedata.com/resource/pubmed/id/12441805
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-20
|
| pubmed:abstractText |
To ascertain the field acceptability and effectiveness of the routine utilization of zidovudine in reducing mother-to-child transmission (MTCT) of HIV in breastfed children after a randomized clinical trial demonstrated its efficacy in Côte d'Ivoire and Burkina Faso.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author |
pubmed-author:DITRAME-ANRS 049 Study Group,
pubmed-author:DabisFrançoisF,
pubmed-author:LeroyValérianeV,
pubmed-author:MandelbrotLaurentL,
pubmed-author:ManigartOlivierO,
pubmed-author:MedaNicolasN,
pubmed-author:MontchoCrépinC,
pubmed-author:MsellatiPhilippeP,
pubmed-author:VihoIdaI,
pubmed-author:YaroSeydouS
|
| pubmed:copyrightInfo |
Copyright 2002 Lippincott Williams & Wilkins
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2323-8
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:articleTitle |
Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa.
|
| pubmed:affiliation |
Centre MURAZ, Bobo-Dioulasso, Burkina Faso, West Africa. nmeda.muraz@fasonet.bf
|